NASDAQ:MGNX

Macrogenics Stock Predictions

Healthcare > Biotechnology

Buy MGNX

*Your capital is at risk

$4.20

+0.150 (+3.70%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

MGNX Prediction Chart

MGNX Predictions History

Latest community submissions for MGNX.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
GoldenNugget Pro	May 7, 2019	$17.69 -0.85%	$17.84	X	99.15%	2
Jacob @Jacob.24742	Apr 30, 2018	$24.00 +4.08%	$23.06	X	95.90%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for MGNX with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT MACROGENICS

MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens. The...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
RUN $12.83	18.86%	May 06
GLBE $31.61	5.35%	May 05
SAP $172.39	10.69%	May 05
W WCLD $27.34	27.18%	Apr 29
ADBE $243.57	7.61%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by